Results 81 to 90 of about 7,267 (158)

Short-Lived Neutralizing Antibody Responses to Monkeypox Virus in Smallpox Vaccine–Naive Persons after JYNNEOS Vaccination

Emerging Infectious Diseases
JYNNEOS, a third-generation smallpox vaccine, is integral to monkeypox virus (MPXV) control efforts, but the durability of this modified vaccinia Ankara–Bavarian Nordic (MVA-BN) vaccine’s effectiveness is undefined.
Kara Phipps, Jennifer Yates, Jessica Pettit, Sean Bialosuknia, Danielle Hunt, Alan P. DuPuis, Anne Payne, William Lee, Kathleen A. McDonough   +8 more
doaj   +1 more source

Seroprevalence among free-ranging birds collected in Córdoba city during 2005 and tested by PRNT for St. Louis encephalitis- and West Nile virus-reactive antibodies.

, 2016
Seroprevalence among free-ranging birds collected in Córdoba city during 2005 and tested by PRNT for St. Louis encephalitis- and West Nile virus-reactive antibodies.
Luis Adrián Diaz (3088692), Juan Javier Aguilar (3088695), Agustín Ignacio Quaglia (3088686), Analia Silvana Boris (3088689), Brenda Salomé Konigheim (3088698), Nicholas Komar (434673), Marta Silvia Contigiani (333927)   +6 more
core   +1 more source

Comparison of IIF titers, PRNT titers and P/N ratios obtained with RT-PCR confirmed sera of seven patients with primary DENV infection.

, 2013
Comparison of IIF titers, PRNT titers and P/N ratios obtained with RT-PCR confirmed sera of seven patients with primary DENV infection.
Petra Emmerich (331026), Herbert Schmitz (502023), Angela Mika (152045)   +2 more
core   +1 more source

Genetic associations with measles PRNT and IgG antibody response to MMR vaccination in 6- and 15-month-old children

BackgroundMeasles immunization is a cornerstone in public health, yet vaccine failure affects up to 10 % of the population, leaving some vaccinated individuals susceptible to infection.
Zimakoff, Anne Cathrine, Malon, Michelle, Svensson, Jannet, Jensen, Andreas, Hatley, Emma Victoria, Kaur, Simranjeet, Kim, Sejun, Vittrup, Dorthe Maria, Stensballe, Lone Graff, Sørensen, Jesper Kiehn, Bybjerg-Grauholm, Jonas, Pociot, Flemming   +11 more
core   +1 more source

Samples on which a PRNT was carried out and/or those that had a positive cELISA result.

, 2015
NT; not tested.NA; not available.Inc.; inconclusive results.aCollection B.bCollection C.The table includes animal species, date of sampling, cELISA results for each sample plus their corresponding S/N % values and PRNT results with antibody titres for a ...
Javier Lopez (5440100), Fieke M. Molenaar (783918), S. Anna La Rocca (783919), Meenakshi Khatri (783920), Falko Steinbach (336180), Akbar Dastjerdi (370258)   +5 more
core   +1 more source

Impact of serum titers of anti-YF neutralizing antibodies on the cytokine-mediated immune response triggered by the YF-17DD and YF-17D-213/77 substrains upon in vitro recall of whole blood leukocytes from seroconverter children (PV-PRNT⁺) with specific YF-Ag.

, 2013
The PRNT+ groups from each experimental arm were first categorized into two subgroups referred to as PV-PRNTMEDIUM+ (2.5≤ serum titers ≤3.5 log10 mIU/mL) and PV-PRNTHIGH+ (serum titers >3.5 log10 mIU/mL). The cytokine profile of the PV-PRNTMEDIUM+ and PV-
Silvana Maria Elói-Santos (294839), Luiz Antonio Bastos Camacho (294826), Reinaldo de Menezes Martins (294827), Akira Homma (294831), Ana Carolina Campi-Azevedo (294819), Marcos da Silva Freire (294830), Ricardo Galler (37871), Olindo Assis Martins-Filho (294842), Denise da Silveira-Lemos (294825), Roberto Henrique Guedes Farias (294829), Maria Luiza-Silva (294822), Marina Angela Martins (294824), Maria de Lourdes de Sousa Maia (294828), Andréa Teixeira-Carvalho (1805704), Luiza Pacheco de Araújo-Porto (294821), Jandira Aparecida Campos Lemos (294833), José Geraldo Leite Ribeiro (294832), Iramaya Rodrigues Caldas (294836), Maria Auxiliadora-Martins (294834), Maurício Azevedo Batista (294823), Renato Sathler-Avelar (294733)   +20 more
core   +1 more source

Characterization of DENV-2 mAbs by IFA, ELISA, WB and PRNT₅₀ (µg/ml).

, 2012
mAbs, monoclonal antibodies; IFA, immunofluorescence assay; ELISA, enzyme-linked immunosorbent assay; WB, Western blotting; PRNT, plaque reduction neutralization test; D1, D2, D3, and D4, DENV-1 to -4; Ig, immunoglobulin; E, envelope protein; E-DI-II ...
Mei-Ying Liao (167265), Chien-Yu Chiu (167280), Han-Chung Wu (167288), Pi-Chun Li (167259), Ping-Chang Cheng (167270), Jian-Jong Liang (155301), I-Ju Liu (167277), Yi-Ling Lin (63628), Gwong-Jen J. Chang (132043)   +8 more
core   +1 more source

Evaluation of three alternative methods to the plaque reduction neutralizing assay for measuring neutralizing antibodies to dengue virus serotype 2

Virology Journal
Background Dengue is a global public health challenge which requires accurate diagnostic methods for surveillance and control. The gold standard for detecting dengue neutralizing antibodies (nAbs) is the plaque reduction neutralization test (PRNT), which
Vanessa Shi Li Goh, Christopher Chong Wei Ang, Swee Ling Low, Pei Xuan Lee, Yin Xiang Setoh, Judith Chui Ching Wong   +5 more
doaj   +1 more source

Dengue virus IgG and neutralizing antibody titers measured with standard and mature viruses are protective

Nature Communications
The standard dengue virus (DENV) neutralization assay inconsistently predicts dengue protection. We compare how IgG ELISA, envelope domain III (EDIII), or non-structural protein 1 (NS1) binding antibodies, and titers from plaque reduction neutralization ...
Camila D. Odio, Jedas Veronica Daag, Maria Vinna Crisostomo, Charlie J. Voirin, Ana Coello Escoto, Cameron Adams, Lindsay Dahora Hein, Rosemary A. Aogo, Patrick I. Mpingabo, Guillermo Raimundi Rodriguez, Saba Firdous, Maria Abad Fernandez, Laura J. White, Kristal An Agrupis, Jacqueline Deen, Aravinda M. de Silva, Michelle Ylade, Leah C. Katzelnick   +17 more
doaj   +1 more source

Age group-wise dengue serotype specific neutralizing antibodies by PRNT in a subset of participants having antibody titers ≥10 (1/dil) against dengue viruses.

, 2018
Age group-wise dengue serotype specific neutralizing antibodies by PRNT in a subset of participants having antibody titers ≥10 (1/dil) against dengue viruses.
Shubham Shrivastava (408570), Akhilesh C. Mishra (137429), Pritam H. Mahadik (5598050), Swapnil A. Gadhave (5598047), Mandar Bhutkar (5598053), Vidya A. Arankalle (188036), Varsha M. Vaidya (5598056)   +6 more
core   +1 more source